IPHA
Innate Pharma
IPHA
IPHA
9 hedge funds and large institutions have $179K invested in Innate Pharma in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$14K | |
| 2 | +$4.11K | |
| 3 | +$2.22K | |
| 4 |
PS
Principal Securities
Des Moines,
Iowa
|
+$82 |
Top Sellers
| 1 | -$112K | |
| 2 | -$6.41K | |
| 3 | -$5.52K | |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$359 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Morgan Stanley
New York
| $93K |
|
|||
2
Citadel Advisors
Miami,
Florida
| $46.6K |
|
|||
3
Millennium Management
New York
| $20.4K |
|
|||
4
UBS Group
Zurich,
Switzerland
| $10.8K |
|
|||
|
GI
5
GAMMA Investing
Foster City,
California
| $6.27K |
|
|||
6
Barclays
London,
United Kingdom
| $1K |
|
|||
|
7
RhumbLine Advisers
Boston,
Massachusetts
| $822 |
|
|||
8
Optiver Holding
Amsterdam,
Netherlands
| $177 |
|
|||
|
PS
9
Principal Securities
Des Moines,
Iowa
| $82 |
|
|||
|
ETC
10
Exchange Traded Concepts
Oklahoma City,
Oklahoma
| – |
|
|||
|
TRCT
11
Tower Research Capital (TRC)
New York
| – |
|